Augmentation therapy with serotonin(1A) receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis

BACKGROUND: In a previous meta-analysis, the use of serotonin(1A)(5-HT(1A)) receptor partial agonists of the azapirone class as an add-on therapy was associated with beneficial effects on positive symptoms and attention/processing speed in schizophrenia patients. This meta-analysis builds on that st...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Risa, Wada, Ayumu, Stickley, Andrew, Yokoi, Yuma, Sumiyoshi, Tomiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507645/
https://www.ncbi.nlm.nih.gov/pubmed/37732133
http://dx.doi.org/10.1016/j.scog.2023.100290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507645/
https://www.ncbi.nlm.nih.gov/pubmed/37732133
http://dx.doi.org/10.1016/j.scog.2023.100290

Ejemplares similares